Invention Grant
US08598204B2 1,2-dihydro-2-oxoquinoline compounds as 5-HT4 receptor ligands 有权
1,2-二氢-2-氧代喹啉化合物作为5-HT 4受体配体

1,2-dihydro-2-oxoquinoline compounds as 5-HT4 receptor ligands
Abstract:
The present invention relates to novel 1,2-dihydro-2-oxoquinoline compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them.The compounds of the present invention are useful in the treatment/prevention of various disorders that are mediated by 5-HT4 receptor activity.
Public/Granted literature
Information query
Patent Agency Ranking
0/0